This year, out of 29 trial decision and verdict cases that arose as patent disputes, companies that filed a trial or lawsuit have won in 21 cases. This translates to a win rate of approximately 76% for companies challenging patents.

Especially, excluding cases where the lawsuit or suit qualification was deemed ineligible, the dispute hadn’t commenced, or was dismissed, generic companies have won all the other disputes, except for the Dukarb dispute.

This year, patent challenging companies have won 22 out of 29 trial decision and verdict cases

According to the pharmaceutical industry on the 26th, 29 cases of trial decisions and verdicts were made on patent disputes, e